https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-allowance-for-credit-loss-not-previously-recorded https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-excluding-accrued-interest-after-allowance-for-credit-loss https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-excluding-accrued-interest https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-gross-unrealized-gain https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/finance-lease-liability-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/income-tax-examination-interest-accrued https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/income-tax-examination-penalties-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/increase-decrease-of-restricted-investments https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/interest-receivable-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/inventory-noncurrent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/investment-income-net https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/investments-and-cash https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/marketable-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/marketable-securities-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/members-equity https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-inventory-acquired https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net-available-for-sale-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/payments-for-tenant-improvements https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restricted-investments-noncurrent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-costs-and-asset-impairment-charges https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/significant-supply-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/sublease-income https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/unbilled-receivables-current https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/deciphera-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted